Is it Time to Reevaluate Our Priorities?

1. Stephanie Sutton, “Beyond the Storm,” The Medicine Maker (2020). Available at: https://bit.ly/2VkGAJq
2. Pfizer, “Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints” (2020). Available at: https://bit.ly/3mnKX1X
3. Moderna, “Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study” (2020). Available at: https://bit.ly/33uKX9a 
4. AstraZeneca, “AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19” (2020). Available at: https://bit.ly/36naZgA 
5. BMJ, “Peter Doshi: Pfizer and Moderna’s “95% effective” vaccines—let’s be cautious and first see the full data” (2020). Available at: https://bit.ly/37gemVG 
6. Stat News, “‘A huge experiment’: How the world made so much progress on a Covid-19 vaccine so fast” (2020). Available at: https://bit.ly/39tpy3S 

About the Author

James Strachan

Over the course of my Biomedical Sciences degree it dawned on me that my goal of becoming a scientist didn’t quite mesh with my lack of affinity for lab work. Thinking on my decision to pursue biology rather than English at age 15 – despite an aptitude for the latter – I realized that science writing was a way to combine what I loved with what I was good at.

From there I set out to gather as much freelancing experience as I could, spending 2 years developing scientific content for International Innovation, before completing an MSc in Science Communication. After gaining invaluable experience in supporting the communications efforts of CERN and IN-PART, I joined Texere – where I am focused on producing consistently engaging, cutting-edge and innovative content for our specialist audiences around the world.